The procedure describes the acylation of the 5′-hydroxy function of N-base-and 2′-Oprotected ribonucleosides with 9-fluorenylmethoxycarbonyl (FMOC) chloride in pyridine at moderately low temperature. The FMOC workup procedure and the chromatographic isolation and 1 H-NMR spectroscopic characterization of the resulting 5′-O-(9-fluorenylmethyl)carbonates S.2a to S.2e (Fig. 2 
A Base-Labile Protecting Group (Fluorenylmethoxycarbonyl) for the 5′-Hydroxy Function of Nucleosides
Once the exocyclic amino functions of a nucleoside have been protected (UNIT 2.1), further functionalization aimed towards assembly into oligonucleotides requires consideration of the specific regioselective protection of the hydroxy groups present in the monomeric building block. Some years ago it was found that, in the case of 2′-deoxynucleosides, the two hydroxy groups (3′-and 5′-) could be satisfactorily differentiated by the application of the triarylmethyl (trityl) family of acid-labile protecting groups for temporary protection of the primary 5′-hydroxy function (UNIT 2.3) . In the case of the ribonucleoside series, however, the differentiation of the three hydroxy groups (2′-, 3′-, and 5′-) has to be achieved at the extremely high level of efficiency required for the iterative steps involved in oligonucleotide assemblies carried out on synthesizer machines. This increased complexity has led to a number of alternative synthetic pathways to oligoribonucleotides, some of which are now commercialized; other pathways remain to be explored more profoundly.
Most of the present oligoribonucleotide synthesis strategies adhere to the popular 5′-Otrityl chemistry and aim at finding solutions for 2′-O-protection (UNIT 2.2), such as the t-butyldimethylsilyl (TBDMS) group, which can be removed by treatment with fluoride ion. In contrast, the authors chose to take advantage of the well-established ketal-type group for 2′-O-protection, which allows final deprotection under particularly mild and isomerization-free acidolytic aqueous conditions at the end of the synthesis (UNIT 2.2), and investigated for 5′-protection the base-labile 9-fluorenylmethoxycarbonyl (FMOC) group as a valuable orthogonal complement. The following Basic Protocol presents a reliable procedure for the regioselective introduction of the FMOC group at the 5′-hydroxy position of nucleosides, starting with deoxythymidine or with 4-methoxytetrahydropyran-4-yl (MTHP)-protected ribonucleosides. The Basic Protocol includes steps for the isolation and characterization of all four 5′-O-FMOC-2′-O-MTHP-protected ribonucleosides and of 5′-O-FMOC-2′-deoxythymidine, which serves as a reference for the deoxyribonucleoside series. No modification is required for 5′-O-FMOC-2′-dA Bz, -dC Bz , or -dG i-Bu (yields are ~65% for dG i-Bu and 70% to 80% for dA Bz and dC Bz ; Balgobin and Chattopadhyaya, 1987; Ma and Sonveaux, 1987) . Additionally, four Support Protocols describe the preparation of the starting N-protected-2′-O-MTHP-ribonucleosides, which are not commercially available and are considered key intermediates for the preparation of the 5′-O-FMOC-protected ribonucleoside building blocks.
Characterization of the various products requires experience in thin-layer chromatography, short column (flash) chromatography, and proton NMR. deoxythymidine (dT; S.1e; Fig. 2 .4.1). Support Protocols 1 to 4 provide a summary for the preparation of the starting key intermediates S.1a to S.1d. Introduce FMOC group 1. Coevaporate 3.0 mmol of 2′-O-MTHP-ribonucleoside or deoxythymidine derivative (S.1a to S.1e) twice from 25 mL dry pyridine under reduced pressure using a rotary evaporator, and then apply a dry nitrogen atmosphere.
Materials

2′-Deoxythymidine or 2′-O-MTHP-ribonucleoside: 2′-O-(4-methoxytetrahydropyran-4-yl)-rU, -rC
2. Dissolve the substrate in a third 25-mL portion of dry pyridine and cool to 0°C.
3. Stir the solution and add 3.6 mmol crystalline FMOC chloride. Stir under nitrogen for 30 min at 0°C.
Normally, all the FMOC chloride will have dissolved by this time.
Check reaction by TLC 4. Resolve products on a silica-coated TLC plate with fluorescent indicator. Develop with diethyl ether followed by 9:1 (v/v) chloroform/methanol.
Predevelopment in diethyl ether is used to disperse the pyridine.
Visualize under UV light (254 nm).
6. Stain by spraying with anisaldehyde reagent and heating on a hot plate at 80°C.
Coloring plates containing nucleoside materials (summarized in Jork et al., 1990) Isolate product by chromatography 7. Terminate the reaction by adding 200 µL of ethane-1,2-diol and concentrate the mixture to an oil using a rotary evaporator with a vacuum pump.
8. Dissolve the oil in 150 mL chloroform and wash with 50 mL saturated aqueous sodium bicarbonate solution. Remove the aqueous phase and wash twice with 50 mL chloroform.
9. Dry the combined chloroform extracts over ~20 g anhydrous sodium sulfate.
10. Filter the dried extract under vacuum with a D4 glass filter crucible, and concentrate under reduced pressure (step 7).
11. Coevaporate the residual oil from ∼50 mL each toluene (twice), ethanol (once), and chloroform (once).
This removes traces of pyridine that are still contained in the dried, concentrated extract (step 10).
12. Apply as concentrated as possible (i.e., in ∼5 mL) to a short 50-g Kieselgel 60H column preconditioned with chloroform. Apply a circular piece of glass-fiber tissue (not sea sand) to the top of the column. Hunt and Rigby (1967) and is similar to the flash chromatography described by Still et al. (1978) .
Short-column chromatography is performed according to
13. Elute minor side products first with chloroform (first 1 to 2 column volumes; 20-mL fraction size), then elute the major product-containing fractions with a gradient of 1% to 5% (v/v) ethanol/chloroform. Do not use >1 atm pressure for elution (Hunt and Rigby, 1967; Still et al., 1978) .
14. Combine the product-containing fractions and concentrate to a foam.
15. Dissolve foam in 5 mL chloroform, precipitate by dropwise addition to 500 mL rapidly stirring pentane, and decant off most of the supernatant (∼450 mL).
16. Collect solids by centrifuging 10 min at 3000 rpm g, 15°C, and decant the pentane.
17. Wash twice by resuspending in 50 mL fresh pentane and repeating the centrifugation. Dry the resulting white powder (S.2a to S.2e) in vacuo using a high vacuum from an oil pump.
Characterize the product 18. Characterize the final product by TLC and 1 H-NMR.
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SUPPORT PROTOCOL 1
PREPARATION OF 2′-O-(4-METHOXYTETRAHYDROPYRAN-4-YL)-URIDINE (S.1a) FROM URIDINE
Starting from uridine (S.3; Fig. 2.4. 3), the desired key intermediate S.1a is obtained by a series of well-described reactions that handle the three ribonucleoside hydroxy groups differentially without protection of the base (Fromageot et al., 1967; Reese et al., 1970; van Boom and Wreesmann, 1984) . Chromatography is necessary only in the last step of the sequence, which makes the procedure particularly useful for the preparation of large amounts of material. In the first step, reaction of uridine (S.3) with trimethyl orthoacetate gives the 2′,3′-methoxyethylidene derivative S.4, which is then acylated at the 5′-OH group to yield S.5. This derivative is cleaved by partial acidic hydrolysis to give a mixture of 2′,5′-di-O-and 3′,5′-di-O-acetates, of which the latter (S.6) can be fractionally crystallized in good yield. Acid-catalyzed ketalization with 5,6-dihydro-4-methoxy-2H-pyran followed by ammonolysis subsequently gives 2′-O-MTHP-uridine (S.1a).
Dioxane (analytical grade), dried by keeping over activated basic aluminum oxide, then distilled before use from sodium/benzophenone after refluxing until the blue color indicates complete dryness Trimethyl orthoacetate (purum, 97%), dried by refluxing over calcium hydride (5 g/L) and distilled under inert atmosphere Pyridine (analytical grade), dried by refluxing over calcium hydride (5 g/L) and then distilled under inert atmosphere Acetic anhydride (analytical grade) Methylene chloride (analytical grade) Saturated (~1 M) aqueous sodium hydrogen carbonate Magnesium sulfate Formic acid (analytical grade) 5,6-Dihydro-4-methoxy-2H-pyran (analytical grade; Sigma or Fluka pract., ~90%; b.p. 20 59° to 61°C) Half-saturated methanolic ammonia solution (see recipe) 500-mL separatory funnel Prepare 2′,3′-methoxyethylidene derivative (S.4) 1. Prepare a mixture of 24.2 g dry uridine (S.3; 100 mmol) 100 mg toluene-p-sulfonic acid monohydrate 150 mL dry dioxane 17 mL dry trimethyl orthoacetate and stir for 6 hr at room temperature.
2. Check the reaction by TLC (see Basic Protocol, steps 4 to 6). 
2.4.6
Prepare 5′-acetylated derivative (S.5) 3. Combine 150 mL dry pyridine and 50 mL acetic anhydride. Add this acylating solution dropwise over 15 min at room temperature to the stirred reaction mixture (step 1), and leave overnight.
Check the reaction by TLC.
TLC should show that the acetylation has gone to completion to yield a product (S.5) with higher mobility (R f = 0.63).
5. Add 50 mL methanol dropwise to the reaction mixture at 0°C to destroy excess acetic anhydride.
6. Concentrate the mixture to a colorless oil under reduced pressure using a rotary evaporator.
7. Dissolve in 250 mL methylene chloride and wash with 100 mL of 1 M aqueous sodium hydrogen carbonate.
8. Extract the aqueous layer five times with 100 mL methylene chloride for each extraction.
9. Dry the combined organic layers over 25 g magnesium sulfate and concentrate to a thick oil.
Prepare 3′,5′-di-O-acetyluridine (S.6)
10. Coevaporate the resulting oil twice from 100 mL ethanol to remove traces of pyridine.
11. Dissolve S.5 in 150 mL of 9:1 (v/v) formic acid/water and incubate 15 min at room temperature.
12. Check the reaction by TLC.
TLC should show that the cleavage of the methoxyethylidene function is complete, yielding 2′,5′-di-O-and 3′,5′-di-O-acetyluridines (R f ≈ 0.4).
13. Evaporate the aqueous formic acid under reduced pressure with a rotary evaporator, and coevaporate the residue twice with 100 mL toluene and twice with 100 mL ethanol.
14. Dissolve in 250 mL chloroform and transfer to a 500-mL separatory funnel containing 150 mL saturated aqueous sodium hydrogen carbonate solution. Shake carefully and separate out the chloroform layer.
15. Extract the aqueous layer twelve times with 50-mL portions of chloroform.
16. Dry the combined chloroform extracts over ~80 g anhydrous sodium sulfate, filter (see Basic Protocol, step 10), and evaporate to a glass.
17. Dissolve the crude product in 500 to 1000 mL boiling ethanol and store the solution for 2 days at room temperature.
18. Filter off the crystals and dry at high vacuum.
19. Determine the isomeric purity by 1 H-NMR spectroscopy. Recrystallize the product if the 2′,5′-isomer is present. (d, J = 7.5, 1H; 5.89 (d, J = 7.5, 1H; 5.88 (d, J = 5.5, 1H; ); the 2′,5′-isomer shows a slightly different J = 7.5, 1H; 5.89 (d, J = 7.5, 1H; 5.86 (d, J = 6.0, 1H; ).
Prepare 2′-O-MTHP-uridine (S.1a)
20. Combine 138 mg toluene-p-sulfonic acid monohydrate and 250 mL dry dioxane and stir until clear.
21. Add 32.8 g of 3′,5′-di-O-acetyluridine (S.6; 100 mmol) and 57 g of 5,6-dihydro-4-methoxy-2H-pyran (57 g, 5.0 eq) to the mixture and stir for 20 hr at room temperature.
22. Check the reaction by TLC.
TLC should indicate complete reaction of the starting material.
Cool the clear solution in an ice water bath.
The solution should be below 0°C to absorb exothermicity during neutralization.
24. Neutralize the reaction mixture by adding 800 µl of half-saturated methanolic ammonia solution.
25. Concentrate under reduced pressure and redissolve in 500 mL methanolic ammonia. Let stand overnight and check the reaction by TLC.
TLC should show complete deacetylation.
26. Evaporate off methanolic ammonia and apply the residue to a column of silica gel (300 g; 12 × 7 cm) packed in methylene chloride. Hunt and Rigby (1967) and is similar to the flash chromatography described by Still et al. (1978) . Do not use air pressure >1 atm.
Short-column chromatography is performed according to
27. Elute the column with the following methylene chloride/methanol solutions: 500 mL of 98:2 (v/v); 500 mL of 96:4 (v/v); 1000 mL of 9:1 (v/v); and 1000 mL of 8:2 (v/v). Combine the product-containing fractions and evaporate to a colorless glass.
28. Dissolve the residue in 25 mL chloroform, precipitate by dropwise addition to 2500 mL rapidly stirring pentane, and decant off most of the supernatant (>2000 mL).
29. Collect solids by centrifuging 10 min at 3000 rpm, 15°C, and decant the pentane.
30. Wash twice by resuspending in 250 mL fresh pentane and repeating the centrifugation. Dry the resulting white powder (S.1a) in vacuo. 2H, ), 4H; 6) of MTHP), 3.90 (m, 1H; ), 3.96 (m, 1H, ), 1H; ), 2H, exchangeable with D 2 O; 5.73 (d, J = 8.1, 1H; 6.00 (d, J = 7.8, 1H; 7.93 (d, 1H; 11.4 (sbr, 1H, exchangeable; .
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A Base-Labile Protecting Group
PREPARATION OF 2′-O-(4-METHOXYTETRAHYDROPYRAN-4-YL)-4-N-BENZOYLCYTIDINE (S.1b) FROM CYTIDINE
In the first step of this procedure, cytidine (S.7; Fig. 2 .4.4) is simultaneously protected on its 3′-and 5′-hydroxy groups by the bifunctional protecting reagent 1,3-dichloro-1,1,3,3-disiloxane (Markiewicz and Wiewerowski, 1985) . The derivative S.8 is formed exclusively, due to the higher reactivity of the sterically more accessible 5′-hydroxy group and the subsequently favorable cyclization to the 3′-hydroxy group. Selective benzoylation on N4 of the base is then achieved by treatment with the active ester 1-hydroxybenzotriazolyl benzoate to give S.9. The latter compound is ketalized at the 2′-hydroxy group upon reaction with 5,6-dihydro-4-methoxy-2H-pyran. Then a solution of n-tetrabutylammonium fluoride in acetonitrile removes the disiloxane protecting group to give 2′-O-MTHP-4-N-benzoylcytidine (S.1b) in good yield (cf. Reese et al., 1970; van Boom and Wreesmann, 1984) . Chromatography is required only for the last step of the sequence.
Additional Materials (also see Basic Protocol and Support Protocol 1)
Cytidine (S.7; Sigma or Fluka), dried before use for 2 hr at 50°C over phosphorus 2. Add 18 mL of 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (62.5 mmol) to 50 mL dry N,N-dimethylformamide and add dropwise to the stirred cytidine solution over a period of 15 min. Stir the reaction mixture for 1 hr at room temperature.
3. Check the reaction by TLC (see Basic Protocol, steps 4 to 6). 4. Neutralize with 75 mL of 2 M triethylammonium bicarbonate buffer and concentrate under reduced pressure to a small volume (100 mL) using a rotary evaporator.
5. Dissolve in 1000 mL methylene chloride and wash with 500 mL of 1 M aqueous sodium hydrogen carbonate followed by 500 mL water.
6. Dry the organic layer over 50 g magnesium sulfate and concentrate to a colorless oil.
7. Crystallize from 500 mL acetone to produce pure 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)cytidine. 17.4, 17.0 13.5, 13.0, 12.5 
3′,5′-O-(
(TIPS).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-4-N-benzoyl-cytidine (S.9) 8. Prepare and stir a solution of the following:
10.0 g dry 1-hydroxybenzotriazole (75 mmol) 300 mL dry dioxane 21 mL dry triethylamine (150 mmol).
9. Combine 8.70 mL benzoyl chloride (75 mmol) and 50 mL dry dioxane, and add dropwise to the above mixture (step 8) over 15 min. Stir for 1 hr at room temperature.
10. Filter off the precipitated triethylammonium chloride salts under inert atmosphere using a glass filter crucible, and add the filtrate to a solution containing 24.25 g of 2′-O-(tetraisopropyldisiloxane-1,3-diyl)cytidine (S.8; 50 mmol) in 150 mL dry N,Ndimethylformamide.
11. Evaporate off a volume of ∼100 mL under reduced pressure and stir the residue at room temperature for 3 days. Check the reaction by TLC.
12. Add 5 mL water and concentrate the reaction mixture under reduced pressure to a small volume (100 mL).
13. Dissolve in 1000 mL methylene chloride and wash as in step 5.
14. Dry the organic layer over 50 g magnesium sulfate and concentrate to a light brown oil.
2.4.10
15. Crystallize from a minimal amount of refluxing acetonitrile to yield analytically pure 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-4-N-benzoylcytidine (S.9). 57.04, H 7.30, N 7.26%; found: C 56.36, H 7.08, N 7 .26%.
3′,5′-O-(
Prepare 2′-O-MTHP-4-N-benzoylcytidine (S.1b)
16. Dissolve 4.75 g toluene-p-sulfonic acid monohydrate (25 mmol) in 125 mL dry dioxane and evaporate under reduced pressure to a colorless oil to remove traces of water.
17. Under an inert atmosphere, add 29.45 g of 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-4-N-benzoylcytidine (S.9; 50 mmol) followed by 250 mL dry dioxane.
18. To the resulting clear solution, add 29 mL of 5,6-dihydro-4-methoxy-2H-pyran (28.5 g; 250 mmol). Stir 20 hr at room temperature and check the reaction by TLC.
TLC should show complete reaction of the starting material.
19. Neutralize the reaction with 3.5 mL half-saturated methanolic ammonia solution (check with moist pH indicator paper) and concentrate immediately under reduced pressure to a small volume (100 mL).
20. Dissolve in 1000 mL methylene chloride and wash as in step 5.
21. Dry the organic layer over 50 g magnesium sulfate and concentrate to a glass.
22. Add 250 mL of 1 M n-tetrabutylammonium fluoride in acetonitrile, stir for 1 hr at room temperature, and check the reaction by TLC.
TLC should show complete removal of the silyl protecting group.
n-Tetrabutylammonium fluoride in acetonitrile must be prepared by the experimenter. Commercially available solutions in tetrahydrofuran can also be used.
23
. Concentrate under reduced pressure to a small volume (100 mL). Dissolve in methylene chloride, wash, and dry as in steps 20 and 21.
24. Dissolve with a minimal amount of dichloromethane and apply to a column of silica gel (300 g; 12 × 7 cm) packed in methylene chloride. Hunt and Rigby (1967) and is similar to the flash chromatography described by Still et al. (1978) . Do not use air pressure >1 atm.
Short-column chromatography is performed according to
25. Elute the column with the following methylene chloride/methanol solutions: 500 mL of 98:2 (v/v); 500 mL of 96:4 (v/v); and 1000 mL of 9:1 (v/v).
26. Collect the main product-containing fractions and evaporate to a glass.
27. Dissolve the residue in 25 mL chloroform, precipitate by dropwise addition to 2500 mL rapidly stirring pentane, and decant off most of the supernatant (>2000 mL).
28. Collect the solids by centrifuging 10 min at 3000 rpm g, 15°C, and decant the pentane. 
2′-O-MTHP-4-N-benzoylcytidine (S.1b): yield 16.1 g (70% from S.9); R f (silica, chloroform/methanol 9:1): 0.43; 1 H-NMR (250 MHz, DMSO-d 6 ): 1.50-1.90 (m×m, 4H; -CH 2 -(3,5) of MTHP), 2.93 (s, 3H; H 3 CO-of MTHP), 3.40-3.60 (m, 2H, -CH 2 -(5′)), 3.5-3.8 (m×m, 4H; -CH 2 -(2,6) of MTHP), 3.96 (m, 1H; -CH-(4′)), 4.02 (m, 1H, -CH-(3′)), 4.39 (m(d×d), 1H; -CH-(2′)), 5.19 (d, J = 6.5, 1H, exchangeable with D 2 O; 3′-OH), 5.25 (t, J = 2.7, 1H, exchangeable with D 2 O; 5′-OH), 6.14 (d, J = 6.8, 1H; -CH-(1′)), 7.36 (d, J = 7.7, 1H; cytidyl-H5), 7.4-8.1 (m×m, 5H; benzoyl-aromatic H), 8.43 (d, 1H; cytidyl-H6), 11.3 (sbr, 1H, exchangeable with D 2 O; cytidyl-N4-H).
SUPPORT PROTOCOL 3
PREPARATION OF 2′-O-(4-METHOXYTETRAHYDROPYRAN-4-YL)-6-N-BENZOYLADENOSINE (S.1c) FROM ADENOSINE
In this protocol, adenosine (S.10, Fig. 2 .4.5) is base protected prior to 3′,5′-disilylation by benzoylation of its crystalline 2′,3′,5′-tri-O-acetyl-derivative (S.11), yielding 6-N-benzoyladenosine (S.12) after deacetylation in situ. The chosen route (cf. Schaller et al., 1963; Reese et al., 1970; Büchi and Khorana, 1972; Jones, 1984; van Boom and Wreesmann, 1984; Markiewicz and Wiewerowski, 1985) is then comparable to the cytidine case (see Support Protocol 2): 3′,5′-disilylation to yield S.13, followed by acid-catalyzed ketalization of the 2′-OH by 5,6-dihydro-4-methoxy-2H-pyran, and cleavage of the silyl protecting group by fluoride ion to yield 2′-O-MTHP-6-N-benzoyladenosine (S.1c) in good chromatographically isolated yield.
Additional Materials (also see Basic Protocol and Support Protocols 1 and 2)
Adenosine (S.10; Sigma or Fluka), dried before use for 2 hr at 50°C over phosphorus pentoxide in vacuo Dry pyridine (see Support Protocol 1 for drying procedure) Acetic anhydride, fractionally distilled with 10% toluene to remove acetic acid 25% (w/v) sodium methoxide in methanol (pract., Aldrich, 
2.4.12
Prepare 2′,3′,5′-tri-O-acetyladenosine (S.11) 1. Prepare and stir a suspension of 10.0 g adenosine (S.10; 37.4 mmol) in 50 mL dry pyridine.
2. Add 23 mL acetic anhydride (0.24 mol) and stir overnight at room temperature.
3. Cool in an ice bath and quench with 40 mL methanol.
4. Remove from the ice bath and stir 1 hr at room temperature.
5. Concentrate to dryness, and recrystallize the white solid residue twice from 100 mL hot ethanol to yield 12.0 g (82%) tri-O-acetyladenosine (S.11). Check the product by TLC (see Basic Protocol, steps 4 to 6).
The product is sufficiently pure (R f = 0.31) for use in the subsequent steps.
Prepare 6-N-benzoyladenosine (S.12) 6. Dissolve crystalline S.11 in 50 mL pyridine, cool in an ice bath, and add 5.3 mL benzoyl chloride (45.8 mmol).
7. Let the reaction mixture warm to room temperature and stir for 2 hr.
8. Quench with 6 mL water and stir for another 30 min.
9. Concentrate to a syrup using a rotary evaporator.
10. Partition the residue between 100 mL chloroform and 100 mL saturated aqueous sodium hydrogen carbonate solution. Reextract the aqueous phase with two 50-mL portions of chloroform.
11. Dry the combined organic extracts over ~20 g anhydrous sodium sulfate and evaporate to a glass (R f = 0.71).
12. Redissolve in 50 mL of 1:1 (v/v) methanol/pyridine, cool on ice, and then add 15 mL (∼3 eq) of 25% sodium methoxide in methanol.
13. Let the reaction mixture warm to room temperature and monitor by TLC.
Deacetylation to the more polar product (R f = 0.24) occurs in <15 min.
14. Neutralize with 4.0 mL acetic acid and evaporate to a small volume (~1 3 ) under reduced pressure.
15. Pour the concentrated product mixture into 100 mL saturated aqueous sodium hydrogen carbonate and extract with 200 mL chloroform.
16. Collect the precipitate that settles between the chloroform and aqueous layers by centrifuging 10 min at 3000 rpm, 15°C.
17. Resuspend in ∼100 mL water and centrifuge again. Repeat with ∼100 mL each ethanol and then diethyl ether.
18. Dry the white solid first in air and then under high vacuum to yield 7.15 g (63%) S.12 as a white solid. Check the product by TLC.
Stir the reaction overnight. Check the reaction by TLC.
22. Add 10 mL methanol, stir for another 15 min, and concentrate under reduced pressure.
23. Take up the residue in 50 mL chloroform and wash sequentially with 25 mL saturated sodium hydrogen carbonate solution, 50 mL of 0.1 M hydrochloric acid, and 30 mL water.
24. Evaporate the organic layer.
25. Remove traces of pyridine by coevaporating with ∼50 mL (once each) toluene, ethanol, and chloroform.
26. Purify the crude product by short-column chromatography (see Basic Protocol, step 12). Elute with chloroform until the product appears, then with chloroform containing 2% (v/v) ethanol (∼700 mL total in 20-mL fractions). Do not use >1 atm pressure for elution (Hunt and Rigby, 1967; Still et al., 1978) .
27. Combine the product-containing fractions, evaporate the solvent, and dry under high vacuum to yield 3.21 g (81%) chromatographically pure S.13 as a colorless foam. Check by TLC (R f = 0.58).
Prepare 2′-O-MTHP-6-N-benzoyladenosine (S.1c)
28. Introduce the MTHP protecting group and perform desilylation (see Support Protocol 2, steps 16 to 30), replacing S.9 (29.45 g; 50 mmol) with the corresponding adenosine derivative S.13 (30.84 g; 50 mmol) to yield S.1c as a dry white powder. 2H, ), 4H; 6) 5.27 (t, J = 5.5, 1H, exchangeable with D 2 O; 5.33 (d, J = 4.5, 1H, exchangeable with D 2 O; 6.19 (d, J = 7.4, 1H; ), 7.5-8.1 (m×m, 5H; benzoyl-aromatic H), 8.77 (2s, 2H; adenyl-H2/8), 11.3 (sbr, 1H, 
2′-O-MTHP-6-N-benzoyladenosine (S.1c): yield 18.9 g (78% from
of MTHP), 4.05 (m, 1H; -CH-(4′)), 4.18 (m, 1H, -CH-(3′)), 5.00 (m(d×d), 1H; -CH-(2′)),
exchangeable with D 2 O; adenyl-N6-H).
SUPPORT PROTOCOL 4
PREPARATION OF 2′-O-(4-METHOXYTETRAHYDROPYRAN-4-YL)-2-N-ISOBUTYRYLGUANOSINE (S.1d) FROM GUANOSINE
Guanosine (S.14; Fig. 2 .4.6) is base protected on N2 (S.16) by reaction with isobutyryl chloride after transiently blocking the 2′-, 3′-, and 5′-hydroxy groups by persilylation (S.15). The chosen route is then comparable to the cytidine and adenosine cases: 3′,5′-disilylation to S.17, followed by acid-catalyzed ketalization of the 2′-OH by 5,6-dihydro-4-methoxy-2H-pyran and cleavage of the silyl protecting group by fluoride ion to yield 2′-O-MTHP-2-N-isobutyrylguanosine (S.1d) in satisfactory isolated yield. Generally, the higher basicity and polarity of guanosine derivatives renders them more difficult to handle, and the yields are frequently compromised by loss of material in aqueous extraction media or on polar silica gel phases. Nevertheless, the proposed sequence is a viable route that is based on well-described literature procedures (Reese et al., 1970; Ti et al., 1982; Jones, 1984; van Boom and Wreesmann, 1984; Markiewicz and Wiewerowski, 1985; McLaughlin et al., 1985) .
Additional Materials (also see Basic Protocol and Support Protocols 1 and 2)
Guanosine (S.14; Sigma or Fluka), dried before use for 2 hr at 50°C over phosphorus pentoxide in vacuo 2. Add 47.5 mL trimethylsilyl chloride (375 mmol) and stir for 3 hr at ambient temperature to produce S.15.
3. Cool to 0°C and add 15.6 mL isobutyryl chloride (150 mmol), dropwise, over a period of 30 min.
4. Allow to warm to room temperature and stir overnight.
5. Cool again to 0°C and quench by adding 50 mL water. Stir for another 10 min at room temperature.
6. Add 100 mL concentrated aqueous ammonia to the clear solution and stir for an additional 30 min.
7. Pour the mixture into 800 mL water and extract with 150 mL methylene chloride.
8. Evaporate the aqueous phase to dryness and crystallize three times from 50 to 100 mL boiling water.
9. Dry the resulting solids for 2 days under high vacuum over phosphorus pentoxide to obtain 7.25 g (41%) 2-N-isobutyrylguanosine (S.16) as a grayish-white, chromatographically homogenous powder. Check by TLC (see Basic Protocol, steps 4 to 6; R f = 0.074).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2-N-isobutyrylguanosine (S.17)
10. Dissolve 7.05 g of 2-N-isobutyrylguanosine (S.16; 20.0 mmol) in 125 mL dry pyridine.
11. Add 6.6 mL of 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (24 mmol) and stir overnight. Check the reaction by TLC.
TLC shows complete reaction of the starting material. 12. Evaporate the suspension and partition between 250 mL chloroform and 250 mL saturated aqueous sodium hydrogen carbonate solution.
13. Reextract the aqueous layer twice with 125 mL chloroform, dry the organic layer over ~30 g sodium sulfate, and evaporate to a glass using a rotary evaporator.
14. Remove traces of pyridine by azeotropic rotoevaporation from 100 mL toluene (twice), 100 mL ethanol (once), and 100 mL chloroform (once).
15. Purify the crude product by short-column chromatography using 200 g silica gel (see Basic Protocol, step 12). Elute with chloroform until the product appears, then with chloroform containing 2% (v/v) ethanol (∼1500 mL total in 30-mL fractions). Do not use >1 atm pressure for elution (Hunt and Rigby, 1967; Still et al., 1978) .
16. Combine the product-containing fractions, evaporate the solvent, and dry under high vacuum to give 7.25 g (61%) chromatographically pure S.17 as a colorless foam. Check by TLC (R f = 0.55).
Prepare 2′-O-MTHP-2-N-isobutyrylguanosine (S.1d)
17. Dissolve 0.95 g of toluene-p-sulfonic acid monohydrate (5 mmol) in 25 mL dry dioxane and evaporate under reduced pressure to a colorless oil to remove traces of water.
18. Under an inert atmosphere, add 5.95 g of 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2-N-isobutyrylguanosine (S.17; 10 mmol) followed by 50 mL dry dioxane.
19. To the resulting clear solution, add 5.8 mL of 5,6-dihydro-4-methoxy-2H-pyran (5.7 g, 50 mmol). Stir 20 hr at room temperature and check the reaction by TLC.
20. Neutralize the reaction with 0.8 mL half-saturated methanolic ammonia solution and concentrate immediately under reduced pressure to a small volume (20 mL).
21. Dissolve the residue in 200 mL chloroform and wash with 100 mL of 1 M aqueous sodium hydrogen carbonate solution.
22. Dry the organic layer over 50 g magnesium sulfate and concentrate to a glass.
23. Add 50 mL of 1 M n-tetrabutylammonium fluoride in acetonitrile, stir for 1 hr at room temperature, and check the reaction by TLC.
TLC should show complete removal of the silyl group.
24. Concentrate under reduced pressure to a small volume (20 mL). Dissolve in chloroform and wash as in step 21.
25. Reextract the aqueous phase twice with 100 mL chloroform.
26. Dry the organic layer over 10 g anhydrous sodium sulfate and concentrate to a glass.
27. Dissolve the residue with minimal amount of chloroform and apply to a column of silica gel (100 g; 8 × 5 cm) packed in chloroform.
28. Elute the column with chloroform until the product appears, and then collect 20-mL fractions with the following chloroform/ethanol solutions: 300 mL of 98:2 (v/v); 300 mL of 96:4 (v/v), 600 mL of 9:1 (v/v).
29. Collect the main product-containing fractions and evaporate to a glass.
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30. Dissolve the residue in 25 mL chloroform, precipitate by dropwise addition to 500 mL rapidly stirring pentane, and decant off most of the supernatant (>400 mL).
31. Collect the solids by centrifuging 10 min at 3000 rpm, 15°C, and decant the pentane.
32. Wash the solids twice by resuspending in 100 mL fresh pentane and repeating the centrifugation. Dry the resulting white powder (S.1d) in vacuo. J = 6.8, 6H; (H 3 C) 2 CH-) ), 4H; 5) of MTHP), 2.55 (s, 3H; 2.75 (septet, J = 6.8, 1H; (H 3 C) 2 CH-) ), 2H, ), 4H; 6) of MTHP), 3.98 (m(t), 1H; ), 4.10 (m(t), 1H, ), 4.74 (m(d×d), 1H; 5.77 (m(t), 1H, exchangeable with D 2 O; 5.19 (m(d), 1H, exchangeable with D 2 O; 6.98 (d, J = 7.9, 1H; 5H; 8.31 (s, 1H; 11.7/12.1 (2sbr, 2H, exchangeable with D 2 O; .
SUPPORT PROTOCOL 5
PREPARATION OF 1,3-DICHLORO-1,1,3,3-TETRAISOPROPYLDISILOXANE
Although this reagent is commercially available (e.g., Fluka), this protocol provides a convenient procedure for its preparation.
Materials
Magnesium curls Dry diethyl ether, distilled from phosphorus pentoxide (30 g/L) Isopropyl bromide, distilled from calcium hydride (5 g/L) Trichlorosilane, freshly distilled 0.1 N hydrochloric acid Magnesium sulfate Methylene chloride (analytical grade), dried by passage through activated basic alumina Chlorine gas, dried over concentrated sulfuric acid NaCl plates for infrared (IR) spectroscopy Additional reagents and equipment for IR spectroscopy Prepare 1,1,3,3-tetraisopropyldisiloxane 1. Combine 64 g magnesium curls and 200 mL dry diethyl ether.
2. Add a solution of 270 mL isopropyl bromide in 400 mL dry diethyl ether dropwise to the solution.
3. Stir the reaction mixture mechanically and heat under reflux for 3.5 hr.
4. Add a solution of 100 mL trichlorosilane and 400 mL dry diethyl ether dropwise to the stirred solution (step 3) and heat under reflux overnight.
5. Quench by adding 800 mL of 0.1 N hydrochloric acid in a dropwise fashion.
6. Stir the mixture and heat under reflux for another 3.5 hr.
7. Separate out the organic layer and extract the aqueous layer three times with 300 mL diethyl ether.
8. Dry the combined organic layers over ~50 g magnesium sulfate and concentrate to a colorless oil under reduced pressure.
9. Distill the residue to produce pure 1,1,3,3-tetraisopropyldisiloxane (100 g; b.p. 80°t o 90°C, 10 mmHg) as a colorless oil.
Prepare 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane 10. Dissolve the above product (100 g of 1,1,3,3-tetraisopropyldisiloxane) in 500 mL methylene chloride and pass a stream of dry chlorine gas through the solution.
Protect the apparatus from atmospheric moisture using a paraffin oil bubbler. Calcium chloride drying tubes are entirely inefficient and will lead to reaction failure.
11. When the temperature rises to ∼27° to 30°C, cool the reaction mixture to 17° to 20°C by immersing it in an ice water bath while continuing the stream of chlorine gas.
12. After 2 hr, and then after every hour, withdraw a small sample of the reaction mixture and analyze by IR spectroscopy using NaCl plates.
13. Stop the chlorination when the IR spectrum indicates the disappearance of the absorption band at 2100 cm −1 (Si-H).
14. Evaporate off the volatile compounds and distill the residue under diminished pressure (b.p. 85° to 90°C, 2 mmHg) to give 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (70 g) as a colorless oil. Store dry at 0°C for up to several months or even years. Anisaldehyde reagent 1 mL 4-methoxybenzaldehyde 2 mL concentrated sulfuric acid 10 mL glacial acetic acid 87 mL methanol (analytical grade) Store up to 6 months at room temperature All analytical-grade reagents are preferred if available.
REAGENTS AND SOLUTIONS
Methanolic ammonia solution, half-saturated (∼8 M)
Pass dry ammonia gas (passed over solid potassium hydroxide pellets) through 500 mL analytical-grade methanol at −20°C until saturation. Dilute with 500 mL analytical-grade methanol. Store up to 4 weeks at -18°C.
Triethylammonium bicarbonate buffer, 2 M Combine 825 mL analytical-grade triethylamine and 2175 mL water. Saturate with carbon dioxide gas at 0°C until the pH of the clear solution reaches 7.5. Store up to 4 weeks at 4°C.
COMMENTARY Background Information
Within the field of solid-phase peptide synthesis, the introduction of a base-labile protecting group for the nucleophilic (amino-) center has been very successful, exceeding by far the status of alternative and becoming a standard technique in many laboratories (Atherton and Sheppard, 1989 , and references cited therein). The base-sensitive amino-protecting 9-fluorenylmethoxycarbonyl (FMOC) group, first introduced by Carpino and Han in 1970 (for a review see Carpino, 1987) , is strictly orthogoCurrent Protocols in Nucleic Acid Chemistry
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nal to the acid-labile protecting groups used for the side chains. Orthogonality is fulfilled when permanent side-chain protecting groups remain completely stable during peptide assembly while being repeatedly exposed to the conditions applied for removal of the temporary terminal protecting group. For solid-phase oligonucleotide assemblies, the use of 5′-O-FMOC chemistry may provide an opportunity for such orthogonality, and also avoids the problem of depurination occasionally observed during repeated acidolytic steps required for 5′-O-detritylation.
Compared to solid-phase peptide synthesis, functional protection is less demanding in oligonucleotide synthesis due to the smaller number of building blocks. In the deoxyribonucleotide series, very satisfactory protecting groups have resulted from the pioneering efforts in the chemical synthesis of genes by the group of Khorana (e.g., Schaller et al., 1963; Büchi and Khorana, 1972) . For example, permanent protection of the exocyclic amino functions as N-acyl and N-aroyl derivatives, respectively, is compatible with nonnucleophilic conditions, but the protecting groups may be cleaved at the very end of the synthesis by hydrolysis in aqueous ammonium hydroxide at elevated temperature.
On the other hand, an adequate treatment of the protecting group strategy in RNA synthesis requires the differential handling of the 2′-, 3′-, and 5′-hydroxy groups. If phosphoramidite chemistry is chosen for chain extension, the central problem is the selection of a suitable combination of the permanent 2′-hydroxylprotecting group together with a temporary 5′-hydroxyl-protecting group. The former must remain intact until the very end of the synthesis, including base deprotection, whereafter it must be removed very cleanly and under conditions that leave the phosphate-ribose backbone in complete constitutional and regiochemical integrity. This was convincingly shown both for the acetal (tetrahydropyranyl or THP) as well as the presently applied 4-methoxytetrahydropyranyl (MTHP) ketal-type of 2′-hydroxylprotecting groups some years ago by the research group of Reese (Norman et al., 1984) . It was demonstrated by HPLC analysis that diuridine and diadenosine phosphates are stable in 0.01 N hydrochloric acid for time periods over ten times longer than that required for complete 2′-deprotection. Moreover, the authors (Christodoulou et al., 1986) and others (Reese and Skone, 1985) showed that if a conventional acid-labile group such as di-O-(p-anisyl)phenylmethyl (dimethoxytrityl or DMTr) or 9-phenylxanthen-9-yl (pixyl or Px) is used to protect the 5′ position, concomitant cleavage of the 2′-O-THP or 2′-O-MTHP takes place to an unacceptable extent. For orthogonal protection of the 5′-hydroxy group, the authors therefore chose the base-labile FMOC protecting group (Fig. 2.4.1 and Fig. 2.4.7) .
FMOC was first proposed for 5′-O-protection in the deoxyribonucleotide series for solidphase synthesis of an octathymidylic acid fragment (Gioeli and Chattopadhyaya, 1982) , and was later used in the same laboratory for the regioselective construction of a 2′-O-pixylprotected dinucleotide (Pathak and Chattopadhyaya, 1985) . Later, the results reported for oligothymidylic acids were extended to deoxyribonucleotide sequences containing 4-Nbenzoyl-2′-deoxycytidine and 6-N-benzoyl-2′-deoxyadenosine, whereby the above procedure for the regioselective introduction of the FMOC group was again confirmed (Ma and Sonveaux, 1987; Balgobin and Chattopadhyaya, 1987 ). An approach for a solution-phase RNA synthesis combining an acid-labile acetal group (1-ethoxyethyl) for 2′-protection with 5′-O-FMOC was proposed by Fukuda et al. (1988) . However, the drawback of using chiral protecting groups on chiral nucleoside building blocks has been commented on with crystallographic data (Lehmann et al., 1991) .
Further efforts to incorporate the FMOC strategy within the framework of solid-phase 
